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1. Introduction 
It is known that low concentrations (0.001-0.05 
pg/ml) of actinomycin D selectively inhibit ribosomal 
RNA (rRNA) synthesis when administered ‘in vivo’ 
[ 1,2]. This effect has been explained on the basis of a 
direct action of the drug on nucleolar transcription 
[3]. However, the same doses of actinomycin D that 
are effective in vivo do not inhibit RNA polymerase I
(EC 2.7.7.6) activity when added to isolated nuclei 
although they do slightly decrease RNA polymerase II 
activity; this result suggested that the specific action 
of the antibiotic on rRNA synthesis might be indirect 
[4]. The observations that after in vivo administra- 
tion of low doses of actinomycin D there is a decrease 
in the RNA polymerase II with a concomitant inhibi- 
tion in the RNA polymerase I activity in the isolated 
nuclei and furthermore, that the time course of this 
inhibition is similar to that found after suppression of 
protein synthesis, lend support to the proposal that 
low doses of actinomycin D affect rRNA synthesis 
through inhibition of the synthesis of messenger 
RNAs (mRNAs) of high turnover which code for 
proteins required for nucleolar activity [S]. In this 
proposal the idea is implied that rRNA synthesis is 
under the control of mRNA synthesis. 
In the forementioned studies rRNA synthesis was 
measured in isolated nuclei or nucleoli [4,5]. In these 
in vitro systems the problem of determining the 
specific activity of the nucleotide precursor pools 
[6,7] is overcome, and therefore they are widely 
used for studying transcription of ribosomal genes 
[4,5,8-131. However, the rate of elongation by RNA 
polymerase I is only l-2% that in vivo [9]. On the 
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other hand, one has to take into consideration the 
side effects that administration of different antibiotics 
might exert in the in vitro assays. With these consider- 
ations in mind we decided to study the effect of pro- 
tein synthesis inhibitors and low doses of actino- 
mycin D on rRNA synthesis by measuring transcrip- 
tion both in vivo and in vitro. 
2. Materials and methods 
2 .l . Obtaining Ehrlich ascites cells 
The cells used were grown for 5-7 days in the 
abdominal cavity of mice. The preparation of the 
cells was carried out as [ 111. Cells were incubated at 
2 X 1 O6 /ml in Eagle’s medium. 
2.2. Nuclear isolation 
.Nuclei were purified as in [ 121. All solutions con- 
tained 1 mM phenylmethanesulfonylfluoride (Sigma), 
2.3. DNAdependen t RNA polymerase I assay 
RNA polymerase I in isolated nuclei was assayed 
by measurement of the incorporation of [3H]UTP 
(New England Nuclear) into RNA as in [12]; the 
assay solution contained phenylmethanesulfonyl- 
fluoride (0.05 mM); cwamanitin, (200 &ml) was 
added to suppress RNA polymerase II and III activities 
[ 141. When heparin (700 I.cg/ml) was included in the 
assay o-amanitin was reduced to 5 Erg/ml since no 
RNA polymerase III activity was detected when 
heparin is present (results not shown). Except for the 
experiments in fig.1 the incubations were done for 
8 min at 37’C. 
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2.4. Labeling and analysis of the RNA 
Cells were labeled with the [3H]nucleoside (New 
England Nuclear) for 10 min; incorporation was halted 
and the RNA was purified as in [ 121. The pelleted 
RNA was dissolved in a buffer containing: 10 n&l 
Tris-HCl (pH 7.6); 1 mM ethylenediamine-tetraacetic 
acid; 100 mM NaCl; 0.5% sodium dodecylsulfate. 
Amounts of RNA corresponding to -1 X 1 O6 cells 
were layered on a 15.30% sucrose gradient in the 
same buffer and centrifuged at 39 000 rev./min for 
4 h and 30 min at 25°C in a MSE-SW 40 rotor. The 
gradients were fractionated and the trichloroacetic 
acid-precipitable radioactivity in each fraction was 
determined [ 151. 
3. Results and discussion 
3 .l . Effect of addition of different antibiotics to 
whole cells on the in vitro assay of nuclear RNA 
polymerase I 
The effect of a low concentration of actinomycin D 
or of pactamycin administered in vivo on the RNA 
polymerase I activity in isolated nuclei is shown in 
fig.1. The kinetics of UMP incorporation is similar in 
nuclei from control and pactamycin-treated cells. The 
reaction stops very soon in both cases, thus suggesting 
that the elongation of RNA chains is the main activity 
that isolated nuclei retain. The initial rate of tran- 
scription and final plateau level in nuclei from cells in 
Time (min) Time (mln) 
Fig.1. Kinetics of RNA polymerase I reaction in nuclei from 
cells treated with different antibiotics. Cells were incubated 
for 2 h and 30 min (-o-), or for 2 h, at which time actino- 
mycin D (0.05 pg/ml) (-A-) or pactamycin (0.3 fig/ml) 
(-•-) was added and incubation continued for 30 min. After 
incubation nuclei were isolated and RNA polymerase I activity 
was assayed without (A) or with (B) heparin. 
which protein synthesis have been inhibited, is -50% 
as compared to control nuclei. These results are in 
agreement with [ 11 ,131. Nuclei from cells incubated 
with the concentration of actinomycin D reported to 
selectively suppress rRNA synthesis [ 1,2], showed a 
substantial enzyme I activity and, unlike the usually 
observed kinetics, the incorporation of [3H]UMP was 
linear (fig.lA). To determine whether this is due to 
reinitiation of RNA chains, polymerase I activity was 
assayed in the presence of heparin. This drug inhibits 
free RNA polymerase molecules but has no effect 
on those already engaged in transcription [9,16]. 
The results in Iig.lB show that heparin abolishes 
polymerase I activity in nuclei from cells treated 
with actinomycin D. On the contrary, in nuclei 
isolated from control and pactamycin-treated cells, 
UMP incorporation is enhanced by the drug. At 
the concentration used in this study, heparin disrupts 
nuclear structure, and the enhancement in transcrip- 
tion is probably similar to that produced by high 
ammonium sulfate [ 161. It is worth noting that the 
decrease in the transcriptional capacity of nuclei after 
protein synthesis inhibition is almost the same whether 
polymerase I is assayed with or without heparin. 
3.2. Effect of different antibiotics on rRNA synthesis 
in whole cells 
The effect of a low concentration of actinomycin D 
or pactamycin on rRNA synthesis measured in whole 
cells is shown in fig.2. After treatment of the cultures 
for 20 min with the inhibitors, the cells were labeled 
with a pulse of [3H]guanosine and the purified RNA 
was analyzed on sucrose gradients. The RNA patterns 
showed that after inhibition of protein synthesis 
there is a substantial incorporation of label into the 
45 S RNA peak which amounts to -50% of that in 
control cells. This result is in good agreement with 
that of in vitro transcription. In the actinomycin D- 
treated cells, no peak of radioactivity could be 
detected in the 45 S region, a finding which correlates 
with the absence of polymerase I activity in the 
isolated nuclei when heparin is included in the assay 
(fig.lB). The correlation between in vivo and in vitro 
results when initiation of RNA chains is suppressed 
by heparin was confirmed in the experiment depicted 
in fig.3, in which the concentration range of actino- 
mycin D that inhibits rRNA synthesis was studied. 
These observations suggested that the polymerase I
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Fig.2. Sedimentation velocity analyses of labeled RNAs from 
cells treated with different antibiotics. Cells were incubated 
for 2 h and at this time actinomycin D (0.05 rg/ml) (-A-), 
or pactamycin (0.3 pg/ml) (-o-) was added; after further 
incubating for 20 min cells were pulse-labeled with [ ‘H]gua- 
nosine (60rCi/ml). Control cells were incubated for 2 h and 
20 mm and pulse-labeled as before (-•--); RNAs were puri- 
fied and analyzed as in section 2. 
activity observed in nuclei from cells treated with a 
low amount of actinomycin D (fig.lA) most probably 
arises from non-specific initiations of RNA chains. 
A possible explanation for this result is based on the 
fact that administration of low doses of actinomycin D 
induce distortion of the helix and extensive DNA 
breakage [ 171, thus creating pseudo-initiator sites for 
molecules of polymerase I not already engaged in 
transcription. 
3.3. Time course of the inhibition of &VA synthesis 
by the different drugs 
Once the conditions for measuring rRNA tran- 
scription in vitro were established, the time course of 
the inhibition of rRNA synthesis by the different 
drugs was studied. If low concentrations of actino- 
mycin D affect rRNA synthesis through inhibition 
of the synthesis of mRNAs which code for proteins 
required for nucleolar activity one might expect that the 
effect of protein synthesis inhibitors should be mani- 
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Fig.3. Effect of addition of different concentrations of 
actinomycin D to whole cells onrRNA synthesis. Cells were 
incubated for 2 h and then exposed to different concentra- 
tions of actinomycin D for 30 min. At this time, cells were 
harvested from an aliquot of the culture, nuclei were isolated 
and RNA polymerase I activity was assayed in the presence 
of heparin (-o-_). To the remaining incubate, [3H]uridme 
(30 &i/ml) was added and incubation was continued for 
10 mm; at this time the RNA was purified and analyzed as in 
section 2; the radioactivity in the 45 S rRNA peak was deter- 
mined graphically [ 12 ] (-a-). For comparison, the data of 
[l] on the inhibition of rRNA synthesis by actinomycin D in 
HeLa cells are included (-a-). 
fested earlier than that of a low dose of actinomycin D. 
As shown in fig.4A, a low concentration of actino- 
mycm D causes a very rapid decrease in rRNA syn- 
thesis, while the decay observed after inhibition of 
protein synthesis with either pactamycin or cyclo- 
heximide is manifested later. That this is not the 
consequence of a delay in the inhibition of protein 
synthesis is illustrated in fig.4B, where a rapid shut 
off of labeled leucine incorporation after administra- 
tion of the antibiotics is seen. 
These results do not support the view that low 
doses of actinomycin D affect rRNA transcription 
through inhibition of the synthesis of certain mRNAs. 
The very early effect of actinomycin D suggests a
direct action of the drug although the data do not 
preclude the possibility of a specific inhibition of 
nucleoplasmic transcripts directly affecting nucleolar 
function. In this regard, it has to be pointed out that 
up to now there is no conclusive evidence for an 
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Fig.4. Time course of the effect of actinomycin D and pro- 
tein synthesis inhibitors on rRNA synthesis. (A) Cells were 
preincubated for 2 h, at which time (time zero), pactamycin 
(0.3 pg/ml) (-o-), cycloheximide (30 r.rg/ml) (-•-), or 
actinomycin D (0.04 Mg/ml) (-A--) was added and incubation 
was continued. At the times indicated nuclei were isolated 
and polymerase I was assayed in the presence of heparin. 
(B) Cells were incubated for 2 h at which time pactamycin 
(0.3 pg/ml) (-o-) or cycloheximide (30 Ccg/ml) (-•-) was 
added and 30 s later 1.2 &i/ml of [ “C]leucine. Control 
cells were incubated for 2 h and labeled as before (-a--). 
After incubating for the times indicated the radioactivity 
incorporated into proteins was measured as in [ 111. 
extranucleolar control of rRNA synthesis, ince the 
experiments inwhich cw-amanitin was administered 
in vivo to specifically suppress nucleoplasmic tran- 
scription gave conflicting results [ 181. 
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